Search results (7)
« Back to Publicationscomparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population
Journal article
Forbes AK. et al, (2025), Nephrology Dialysis Transplantation, 40, 71 - 82
ZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Journal article
Meeraus W. et al, (2024), Journal of Infection, 88
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study
Journal article
Forbes AK. et al, (2024), Eclinicalmedicine, 68
Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and Validation
Journal article
Kar D. et al, (2024), Journal of Medical Internet Research, 26
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study
Journal article
Whitaker HJ. et al, (2023), Journal of Infection, 87, 315 - 327
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort
Journal article
Joy M. et al, (2023), The Lancet Regional Health - Europe, 32